Old Mission Capital LLC Genmab A/S Transaction History

Old Mission Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$34.88 - $43.22 $1.34 Million - $1.67 Million	38,552 New	38,552 $1.46 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $306,784 - $3.64 Million	9,733 New	9,733 $313,000
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $412,611 - $559,308	-12,549 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$30.92 - $44.4 $388,015 - $557,175	12,549 New	12,549 $412,000
Q4 2019 Feb 14, 2020	SELL	$18.88 - $24.14 $3.93 Million - $5.03 Million	-208,363 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $3.75 Million - $4.45 Million	208,363 New	208,363 $4.22 Million

240

52.6M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $14.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.